Peptides and Peptidomimetics as Inhibitors of Enzymes Involved in Fibrillar Collagen Degradation.

Patrycja Ledwoń, Anna Maria Papini, Paolo Rovero, Rafal Latajka
Author Information
  1. Patrycja Ledwoń: Department of Bioorganic Chemistry, Faculty of Chemistry, Wroclaw University of Science and Technology, 50-370 Wroclaw, Poland. ORCID
  2. Anna Maria Papini: Interdepartmental Research Unit of Peptide and Protein Chemistry and Biology, Department of Chemistry "Ugo Schiff", University of Florence, 50019 Sesto Fiorentino, Firenze, Italy. ORCID
  3. Paolo Rovero: Interdepartmental Research Unit of Peptide and Protein Chemistry and Biology, Department of Neurosciences, Psychology, Drug Research and Child Health-Section of Pharmaceutical Sciences and Nutraceutics, University of Florence, 50019 Sesto Fiorentino, Firenze, Italy. ORCID
  4. Rafal Latajka: Department of Bioorganic Chemistry, Faculty of Chemistry, Wroclaw University of Science and Technology, 50-370 Wroclaw, Poland. ORCID

Abstract

Collagen fibres degradation is a complex process involving a variety of enzymes. Fibrillar collagens, namely type I, II, and III, are the most widely spread collagens in human body, e.g., they are responsible for tissue fibrillar structure and skin elasticity. Nevertheless, the hyperactivity of fibrotic process and collagen accumulation results with joints, bone, heart, lungs, kidneys or liver fibroses. Per contra, dysfunctional collagen turnover and its increased degradation leads to wound healing disruption, skin photoaging, and loss of firmness and elasticity. In this review we described the main enzymes participating in collagen degradation pathway, paying particular attention to enzymes degrading fibrillar collagen. Therefore, collagenases (MMP-1, -8, and -13), elastases, and cathepsins, together with their peptide and peptidomimetic inhibitors, are reviewed. This information, related to the design and synthesis of new inhibitors based on peptide structure, can be relevant for future research in the fields of chemistry, biology, medicine, and cosmeceuticals.

Keywords

References

  1. J Mol Biol. 2001 Mar 23;307(2):577-86 [PMID: 11254383]
  2. Biopolymers. 2002;66(2):79-92 [PMID: 12325158]
  3. J Biol Chem. 2011 Sep 9;286(36):31761-70 [PMID: 21715326]
  4. Am J Physiol Lung Cell Mol Physiol. 2001 Oct;281(4):L868-78 [PMID: 11557590]
  5. Matrix Biol. 2019 Jan;75-76:190-200 [PMID: 29162487]
  6. Biochemistry. 1992 Aug 11;31(31):7152-4 [PMID: 1322694]
  7. J Biol Chem. 2008 Jan 11;283(2):1043-51 [PMID: 17991740]
  8. Adv Wound Care (New Rochelle). 2016 Jan 1;5(1):1-10 [PMID: 26858910]
  9. Molecules. 2012 Nov 30;17(12):14230-48 [PMID: 23201642]
  10. Clin Orthop Relat Res. 1992 Sep;(282):250-72 [PMID: 1516320]
  11. PLoS Negl Trop Dis. 2017 Feb 21;11(2):e0005343 [PMID: 28222138]
  12. J Appl Physiol (1985). 2006 Jun;100(6):2012-23 [PMID: 16497837]
  13. Proc Natl Acad Sci U S A. 2014 Dec 9;111(49):17474-9 [PMID: 25422423]
  14. Biochimie. 2005 Mar-Apr;87(3-4):249-63 [PMID: 15781312]
  15. J Antibiot (Tokyo). 1972 Apr;25(4):263-6 [PMID: 4559651]
  16. PLoS One. 2018 Mar 29;13(3):e0194458 [PMID: 29596429]
  17. Chem Biol. 2000 Feb;7(2):119-32 [PMID: 10662694]
  18. J Biochem. 2000 Dec;128(6):1051-7 [PMID: 11098149]
  19. Sci Rep. 2019 Apr 1;9(1):5399 [PMID: 30931961]
  20. Vasa. 2018 Jun;47(4):285-293 [PMID: 29624112]
  21. Front Biosci. 2006 Sep 01;11:3100-20 [PMID: 16720379]
  22. J Glaucoma. 2014 Oct-Nov;23(8 Suppl 1):S20-3 [PMID: 25275899]
  23. Biochim Biophys Acta. 1977 Nov 23;485(1):156-66 [PMID: 562189]
  24. J Antibiot (Tokyo). 1969 Jun;22(6):283-6 [PMID: 5810993]
  25. J Biol Chem. 2007 Sep 14;282(37):26948-26955 [PMID: 17626018]
  26. Bioorg Med Chem Lett. 2008 Feb 1;18(3):923-8 [PMID: 18226527]
  27. Expert Opin Drug Discov. 2016;11(1):79-90 [PMID: 26757171]
  28. ChemMedChem. 2016 Aug 19;11(16):1850-5 [PMID: 26615979]
  29. Clin Dermatol. 2008 Nov-Dec;26(6):627-32 [PMID: 18940543]
  30. Chem Biodivers. 2021 Feb;18(2):e2000833 [PMID: 33348441]
  31. Nature. 1949 Sep 17;164(4168):491 [PMID: 18140457]
  32. Biopolymers. 2008 May;89(5):345-53 [PMID: 18275087]
  33. J Med Chem. 1994 Aug 19;37(17):2713-20 [PMID: 8064799]
  34. Expert Opin Ther Pat. 2011 Mar;21(3):339-54 [PMID: 21235378]
  35. Cells. 2020 May 25;9(5): [PMID: 32466129]
  36. Am J Physiol Heart Circ Physiol. 2006 Dec;291(6):H2924-32 [PMID: 16891407]
  37. Biochem Biophys Res Commun. 2000 Aug 28;275(2):401-5 [PMID: 10964677]
  38. Expert Opin Investig Drugs. 2000 Sep;9(9):2167-77 [PMID: 11060801]
  39. Methods Mol Med. 2005;117:189-207 [PMID: 16118453]
  40. Photochem Photobiol. 2001 Aug;74(2):283-90 [PMID: 11547567]
  41. J Appl Physiol (1985). 2007 Feb;102(2):541-6 [PMID: 16990502]
  42. Nat Med. 2000 Jun;6(6):698-702 [PMID: 10835689]
  43. Front Chem. 2019 Mar 26;7:155 [PMID: 30972322]
  44. J Am Chem Soc. 2012 Feb 1;134(4):2100-10 [PMID: 22239621]
  45. Cell Biol Int. 2018 Sep;42(10):1340-1348 [PMID: 29908000]
  46. Cold Spring Harb Perspect Biol. 2011 Dec 01;3(12): [PMID: 21917992]
  47. Chem Biol. 2003 Oct;10(10):997-1001 [PMID: 14583266]
  48. J Hepatol. 2016 Jan;64(1):103-9 [PMID: 26307398]
  49. Biochem J. 1994 Oct 1;303 ( Pt 1):323-7 [PMID: 7945258]
  50. Planta Med. 2015 Jul;81(10):813-20 [PMID: 26039265]
  51. Pharmacol Ther. 1997;75(1):69-75 [PMID: 9364582]
  52. Front Chem. 2021 May 20;9:674705 [PMID: 34095086]
  53. Chemistry. 2018 Jan 19;24(4):953-961 [PMID: 29160605]
  54. Respir Res. 2001;2(5):300-5 [PMID: 11686900]
  55. PLoS One. 2013;8(1):e53343 [PMID: 23308198]
  56. Protein J. 2020 Apr;39(2):97-105 [PMID: 32072438]
  57. J Med Chem. 2013 Aug 8;56(15):6259-72 [PMID: 23844670]
  58. Int J Pept Res Ther. 2012 Dec;18(4):335-339 [PMID: 24496015]
  59. J Bone Miner Res. 1997 Sep;12(9):1396-406 [PMID: 9286755]
  60. Phytochemistry. 2001 Dec;58(7):1087-95 [PMID: 11730873]
  61. J Med Chem. 2008 Oct 23;51(20):6410-20 [PMID: 18811135]
  62. J Biol Chem. 2014 Aug 29;289(35):24091-101 [PMID: 25008319]
  63. Matrix Biol. 2009 Jul;28(6):373-9 [PMID: 19398000]
  64. J Invest Dermatol. 2001 Sep;117(3):671-7 [PMID: 11564175]
  65. Protein Sci. 2008 Jan;17(1):66-71 [PMID: 18042679]
  66. Biochem Pharmacol. 2019 Jun;164:188-204 [PMID: 30905657]
  67. Osteoporos Int. 2011 Dec;22(12):3001-11 [PMID: 21308366]
  68. Proc Natl Acad Sci U S A. 1989 Jan;86(1):7-11 [PMID: 2911584]
  69. Bioorg Med Chem. 2018 Oct 1;26(18):4984-4995 [PMID: 30249495]
  70. Biochemistry. 2003 Dec 30;42(51):15018-28 [PMID: 14690410]
  71. Am J Physiol Endocrinol Metab. 2006 Jan;290(1):E163-E168 [PMID: 16131512]
  72. Annu Rev Physiol. 2017 Feb 10;79:593-617 [PMID: 27959618]
  73. Biochemistry. 2003 May 13;42(18):5414-20 [PMID: 12731883]
  74. J Biol Chem. 2013 Mar 29;288(13):8785-93 [PMID: 23430258]
  75. Bioorg Med Chem. 2004 Nov 1;12(21):5689-710 [PMID: 15465346]
  76. Biochimie. 2005 Mar-Apr;87(3-4):393-402 [PMID: 15781327]
  77. Anal Biochem. 2009 Mar 15;386(2):181-5 [PMID: 19111518]
  78. Fibrogenesis Tissue Repair. 2011 Oct 05;4:22 [PMID: 21970406]
  79. J Invest Dermatol. 1982 Jul;79 Suppl 1:77s-82s [PMID: 6806401]
  80. J Enzyme Inhib. 1990;3(3):195-201 [PMID: 2079636]
  81. Biomarkers. 2008 Feb;13(1):79-87 [PMID: 17852072]
  82. J Enzyme Inhib Med Chem. 2016;31(sup1):177-183 [PMID: 27028474]
  83. Chembiochem. 2015 May 4;16(7):1084-92 [PMID: 25766890]
  84. Curr Opin Clin Nutr Metab Care. 2007 Sep;10(5):582-90 [PMID: 17693741]
  85. Biol Chem. 2003 Jun;384(6):863-72 [PMID: 12887053]
  86. Pathol Biol (Paris). 1988 Nov;36(9):1133-8 [PMID: 3065704]
  87. Curr Pharm Des. 2005;11(19):2501-14 [PMID: 16026303]
  88. Expert Opin Ther Pat. 2011 Oct;21(10):1611-29 [PMID: 21923554]
  89. Biopolymers. 2011;96(1):1-3 [PMID: 20225219]
  90. Eur Heart J. 1995 May;16 Suppl C:38-44 [PMID: 7556271]
  91. Crit Rev Biochem Mol Biol. 2010 Apr;45(2):106-24 [PMID: 20199358]
  92. Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2464-72 [PMID: 21903941]
  93. Expert Opin Ther Targets. 2008 Feb;12(2):145-57 [PMID: 18208364]
  94. Biochem Biophys Res Commun. 1986 Apr 14;136(1):390-5 [PMID: 3010973]
  95. Cells. 2019 Mar 20;8(3): [PMID: 30897858]
  96. Coll Relat Res. 1987 Jun;7(2):93-104 [PMID: 3497767]
  97. J Med Chem. 2007 Oct 4;50(20):4928-38 [PMID: 17850059]
  98. IUBMB Life. 2005 Mar;57(3):161-72 [PMID: 16036578]
  99. Front Chem. 2020 Oct 30;8:572923 [PMID: 33195061]
  100. ACS Chem Biol. 2020 Mar 20;15(3):751-757 [PMID: 31935054]
  101. Asian Pac J Trop Biomed. 2014 May;4(Suppl 1):S348-52 [PMID: 25183109]
  102. Biopolymers. 2000 Apr 15;53(5):434-45 [PMID: 10738204]
  103. Eur J Biochem. 1995 Mar 15;228(3):830-41 [PMID: 7737183]
  104. J Med Chem. 2017 Jul 13;60(13):5816-5825 [PMID: 28653849]
  105. Mol Vis. 2013 Jul 20;19:1591-9 [PMID: 23882137]
  106. J Am Chem Soc. 2007 Aug 29;129(34):10408-17 [PMID: 17672455]
  107. FASEB J. 2013 Nov;27(11):4395-405 [PMID: 23913860]
  108. EMBO J. 1994 Mar 15;13(6):1263-9 [PMID: 8137810]
  109. Biochem Pharmacol. 2005 Aug 15;70(4):535-44 [PMID: 15992779]
  110. J Thromb Haemost. 2016 Mar;14(3):438-48 [PMID: 26749406]
  111. Bioorg Med Chem. 2005 Feb 1;13(3):609-25 [PMID: 15653329]
  112. Arch Dermatol Res. 2002 Jul;294(4):185-9 [PMID: 12111349]
  113. Front Pharmacol. 2020 Jun 05;11:688 [PMID: 32581778]
  114. J Med Chem. 2005 Dec 1;48(24):7520-34 [PMID: 16302794]
  115. J Biol Chem. 2003 Jul 4;278(27):24986-93 [PMID: 12700244]
  116. Biochem J. 1998 May 1;331 ( Pt 3):727-32 [PMID: 9560298]
  117. Bioorg Med Chem. 2011 Aug 1;19(15):4460-72 [PMID: 21741848]
  118. J Antibiot (Tokyo). 1994 Dec;47(12):1359-64 [PMID: 7844029]
  119. Am J Pathol. 2005 Oct;167(4):1119-24 [PMID: 16192646]
  120. Biochem J. 1998 Mar 1;330 ( Pt 2):897-902 [PMID: 9480907]
  121. Eur J Pharmacol. 2011 Sep;666(1-3):53-60 [PMID: 21658384]
  122. Am J Physiol. 1987 Jan;252(1 Pt 1):C1-9 [PMID: 3544859]
  123. Adv Drug Deliv Rev. 2003 Nov 28;55(12):1531-46 [PMID: 14623400]
  124. J Org Chem. 2008 Aug 1;73(15):5663-74 [PMID: 18489158]
  125. Curr Top Med Chem. 2010;10(3):294-322 [PMID: 20166952]
  126. J Biol Chem. 2006 Feb 10;281(6):3494-504 [PMID: 16330543]
  127. Expert Opin Investig Drugs. 2009 May;18(5):585-600 [PMID: 19388876]

Grants

  1. BIOPEPTIDI. Sviluppo di nuovi peptidi biologicamente attivi. POR CREO FESR 2007-2013 ASSE I-LINEA DI INTERVENTO 1.1.c./Regione Toscana
  2. /Polish Ministry of Science and Higher Education for the Faculty of Chemistry of Wroclaw University of Science and Technology

Word Cloud

Created with Highcharts 10.0.0collagendegradationenzymesinhibitorsCollagenprocessFibrillarcollagensfibrillarstructureskinelasticitypeptidecosmeceuticalsfibrescomplexinvolvingvarietynamelytypeIIIIIwidelyspreadhumanbodyegresponsibletissueNeverthelesshyperactivityfibroticaccumulationresultsjointsboneheartlungskidneysliverfibrosesPercontradysfunctionalturnoverincreasedleadswoundhealingdisruptionphotoaginglossfirmnessreviewdescribedmainparticipatingpathwaypayingparticularattentiondegradingThereforecollagenasesMMP-1-8-13elastasescathepsinstogetherpeptidomimeticreviewedinformationrelateddesignsynthesisnewbasedcanrelevantfutureresearchfieldschemistrybiologymedicinePeptidesPeptidomimeticsInhibitorsEnzymesInvolvedDegradationenzymepeptidespeptidomimetics

Similar Articles

Cited By